The tumor suppressor miR-217 is reported to inhibit MALAT1 through the Ago2-mediated pathway in order to inhibit EMT-related metastasis through upregulating E-cadherin and N-cadherin suppression (64). Here, MALAT1 is linked to neoplasm.